Cerenome (CNSY) Free Cash Flow (2010 - 2026)
Analysis
Cerenome (CNSY) Free Cash Flow (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -7.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.63 Mn |
| Mar 31, 2026 | -7.06 Mn |
| Dec 31, 2025 | -6.31 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Jun 30, 2025 | -5.81 Mn |
| Mar 31, 2025 | -6.18 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -3.69 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -4.55 Mn |
| Dec 31, 2023 | 634,000.00 |
| Sep 30, 2023 | -2.41 Mn |
| Jun 30, 2023 | -2.79 Mn |
| Mar 31, 2023 | -5.89 Mn |
| Dec 31, 2022 | -5.25 Mn |
| Sep 30, 2022 | -3.23 Mn |
| Jun 30, 2022 | -2.78 Mn |
| Mar 31, 2022 | -4.09 Mn |
| Dec 31, 2021 | -2.63 Mn |
| Sep 30, 2021 | -2.31 Mn |